Defense Secretary Pete Hegseth’s new testosterone screening and treatment program for troops is sparking legal scrutiny as a federal judge probes whether it unfairly distinguishes between transgender men and other service members receiving hormone therapy. The judge, overseeing a lawsuit challenging the transgender service member ban, demands clarity on medical and logistical overlaps — especially as Hegseth frames the initiative as voluntary and aimed at peak performance. While experts debate the merits of treating age-related testosterone decline, the Pentagon’s selective application of hormone therapy is now under judicial microscope, amid ongoing legal battles over transgender service eligibility.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
